Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine

The 22q11.2 deletion syndrome (22q11.2DS) confers high risk of neurodevelopmental disorders such as schizophrenia and attention-deficit hyperactivity disorder. These disorders are associated with attentional impairment, the remediation of which is important for successful therapeutic intervention. W...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Psychiatry
Main Authors: Nilsson, Simon R. O., Heath, Christopher J., Takillah, Samir, Didienne, Steve, Fejgin, Kim, Nielsen, Vibeke, Nielsen, Jacob, Saksida, Lisa M., Mariani, Jean, Faure, Philippe, Didriksen, Michael, Robbins, Trevor W., Bussey, Timothy J., Mar, Adam C.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6235862/
https://ncbi.nlm.nih.gov/pubmed/30429456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-018-0295-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados